tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Henriksson, 4 are a BUY (100%).
Analyst Matthew Henriksson, currently employed at CITI, carries an average stock price target met ratio of 100% that have a potential upside of 17.02% achieved within 400 days.
Matthew Henriksson’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on GMED, Globus Medical at 05-Aug-2021.
Analyst best performing recommendations are on GMED (GLOBUS MEDICAL).
The best stock recommendation documented was for GMED (GLOBUS MEDICAL) at 2/18/2021. The price target of $77 was fulfilled within 127 days with a profit of $13.5 (21.26%) receiving and performance score of 1.67.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 20-May-2024
$115
$21.53 (23.03%)
$80
12 days ago
(08-Jan-2026)
19/21 (90.48%)
$20.38 (21.54%)
368
Buy
Since 18-Nov-2025
$105
$11.53 (12.34%)
$93
2 months 2 days ago
(18-Nov-2025)
28/30 (93.33%)
$21.58 (25.87%)
322
Buy
Since 17-Jun-2013
$114
$20.53 (21.96%)
$103
2 months 10 days ago
(10-Nov-2025)
21/23 (91.3%)
$27.64 (32.01%)
359
Buy
Since 07-Aug-2024
$79
$-14.47 (-15.48%)
$93
2 months 13 days ago
(07-Nov-2025)
12/13 (92.31%)
$17.29 (28.02%)
240
Hold
Since 08-Jan-2025
$91
$-2.47 (-2.64%)
$97
2 months 13 days ago
(07-Nov-2025)
9/10 (90%)
$29.29 (47.46%)
426
What Year was the first public recommendation made by Matthew Henriksson?
